Who
AH Bio Fund II, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Scribe Therapeutics; 10% owner, Nautilus Biotechnology.
In numbers
- Trades disclosed
- 7
- Buys
- 1
- Sells
- 1
- Bought
- $5.0M
- Sold
- $11.8M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 2 Jun 2026
- Last trade
- 27 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Code C | —2,051,742 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Code C | —697,650 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Bought | $5.0M333,333 at $15.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —12,150,003 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —4,131,344 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Sold | $10.8M4,615,974 at $2.35 | filing |
| 2 Jun 2026filed 4 Jun 2026 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Sold | $902K384,026 at $2.35 | filing |
News
No headline names them, or the companies they trade most, lately.